Jenna Davidner
Stock Analyst at Barclays
(2.44)
# 2,840
Out of 4,495 analysts
22
Total ratings
53.3%
Success rate
4.5%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jenna Davidner
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TARS Tarsus Pharmaceuticals | Maintained: Buy | $100 | $64.14 | +55.91% | 6 | Jul 10, 2026 | |
| COLL Collegium Pharmaceutical | Maintained: Buy | $56 | $35.81 | +56.38% | 6 | Jul 1, 2026 | |
| PHAT Phathom Pharmaceuticals | Maintained: Buy | $18 | $12.16 | +48.03% | 3 | May 15, 2026 | |
| PCRX Pacira BioSciences | Maintained: Hold | $25 | $25.50 | -1.96% | 4 | May 14, 2026 | |
| XERS Xeris Biopharma Holdings | Rated: Buy | $9 | $8.62 | +4.41% | 3 | May 13, 2026 |
Tarsus Pharmaceuticals
Jul 10, 2026
Maintained: Buy
Price Target: $100
Current: $64.14
Upside: +55.91%
Collegium Pharmaceutical
Jul 1, 2026
Maintained: Buy
Price Target: $56
Current: $35.81
Upside: +56.38%
Phathom Pharmaceuticals
May 15, 2026
Maintained: Buy
Price Target: $18
Current: $12.16
Upside: +48.03%
Pacira BioSciences
May 14, 2026
Maintained: Hold
Price Target: $25
Current: $25.50
Upside: -1.96%
Xeris Biopharma Holdings
May 13, 2026
Rated: Buy
Price Target: $9
Current: $8.62
Upside: +4.41%